scPharmaceuticals, Inc. (SCPH)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about scPharmaceuticals, Inc. (SCPH)
Company Performance

Current Price

as of Oct 16, 2024

$4.41

P/E Ratio

N/A

Market Cap

$220.63M

Description

scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure and scCeftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.

Metrics

Overview

  • HQBurlington, MA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerSCPH
  • Price$4.41+3.52%

Trading Information

  • Market Cap$220.63M
  • Float70.41%
  • Average Daily Volume (1m)318,180
  • Average Daily Volume (3m)300,395
  • EPS-$1.56

Company

  • Revenue$24.05M
  • Rev Growth (1yr)391.70%
  • Net Income-$17.09M
  • Gross Margin70.80%
  • EBITDA Margin-178.53%
  • EBITDA-$14.38M
  • EV$172.44M
  • EV/Revenue7.17
  • P/EN/A
  • P/S7.15
  • P/B17.23
Documents